Moreover, it was observed that PD-L1 expression on cancer cells also drives Akt/mTOR signaling [219,262], thus boosting tumor glycolysis with the subsequent depletion of environmental glucose and a restriction of T-cell functions [219]. Here, AKT1 is linked to cancer.